When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs
.
With a flagship treatment that helps fewer than 11,000 people, how is Alexion making so much money?
.
Fecha: May 25, 2017 at 05:50PM
via Digg Health: http://ift.tt/2qXFqDJ
Página multilingual - Multi language page
No hay comentarios.:
Publicar un comentario